phenyl-2-isopropyl-5-oxovaleronitrile | 103545-98-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: phenyl-2-isopropyl-5-oxovaleronitrile
• 英文别名: α-(2-formylethyl)-α-isopropyl-α-phenylacetonitrile；4-cyano-5-methyl-4-phenylhexanal；4-phenyl-4-cyano-5-methylhexanal；2-(1-methylethyl)-5-oxo-2-phenyl pentane nitrile；2-(1-Methylethyl)-5-oxo-2-phenylpentane nitrile；5-oxo-2-phenyl-2-propan-2-ylpentanenitrile
• CAS: 103545-98-8
• 化学式: C₁₄H₁₇NO
• 分子量: 215.295
• InChiKey: OAXSBPRAPYEPGP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  16
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  40.9
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  phenyl-2-isopropyl-5-oxovaleronitrile 在 三乙酰氧基硼氢化钠 、 溶剂黄146 、 三苯基膦 、 偶氮二甲酸二乙酯 作用下， 以 1,2-二氯乙烷 为溶剂， 反应 3.0h， 生成 1-[(4-cyano-5-methyl-4-phenyl)hexyl]-4-[2-(4-chlorophenoxy)ethyl]piperazine
  参考文献：
  名称：

  Discovery of novel neuronal voltage-Dependent calcium channel blockers based on emopamil left hand as a bioactive template

  摘要：

  A series of novel neuronal voltage-dependent calcium channel (VDCC) blockers, with inhibitory activity at low micromolar and moderate solubility in water, was discovered by constructing and screening a focused library based on emopamil (1) left hand (ELH) as a bioactive template. (C) 2003 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)01070-3
• 作为产物：
  描述：

  在 盐酸 作用下， 以 丙酮 为溶剂， 生成 phenyl-2-isopropyl-5-oxovaleronitrile
  参考文献：
  名称：

  Discovery of novel neuronal voltage-Dependent calcium channel blockers based on emopamil left hand as a bioactive template

  摘要：

  A series of novel neuronal voltage-dependent calcium channel (VDCC) blockers, with inhibitory activity at low micromolar and moderate solubility in water, was discovered by constructing and screening a focused library based on emopamil (1) left hand (ELH) as a bioactive template. (C) 2003 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)01070-3

文献信息

• Novel N-substituted alpha aminoacid amides as calcium channel modulators
  申请人：LILLY INDUSTRIES LIMITED

  公开号：EP0805147A1

  公开（公告）日：1997-11-05

  The compounds of formula I and derivatives thereof have been found to be active in tests that show modulation of voltage-dependent calcium channels, and are thus indicated for use in the treatment of diseases in which such modulation is beneficial, in particular diseases of the central nervous system.

  公式I及其衍生物的化合物已被发现在显示调节电压依赖性钙通道的测试中具有活性，因此适用于治疗对此类调节有益的疾病，特别是中枢神经系统疾病。
• Novel phenoxyalkylamine derivatives. V. Synthesis, .ALPHA.-blocking activity and quantitative structure-activity analysis of .ALPHA.-((phenoxyethylamino)propyl)-.ALPHA.-phenylacetonitrile derivatives.
  作者：KAZUYA MITANI、SHUNICHIRO SAKURAI、TOSHIHIRO SUZUKI、KOJI MORIKAWA、EIICHI KOSHINAKA、HIDEO KATO、YASUO ITO、TOSHIO FUJITA

  DOI：10.1248/cpb.36.4121

  日期：——

  α-[(Phenoxyethylamino) propyy]-α-phenylacetonitrile derivatives possessing various substituents on the benzene ring (A ring) at the phenylacetonitrile moiety, on the quaternary carbon atom and on the benzene ring (B ring) at the phenoxy moiety, and exhibiting various degrees of ablocking activity, were prepared. The variations in the activity were analyzed qualitatively as well as quantitatively by using physicochemical substituent parameters and a regression technique. The effect of substituents on the A ring was rationalized in terms of a parabolic function of their hydrophobic parameter. As regards substituents on the quaternary carbon atom, alkyl groups were desirable for high activity. The effects of substituents on the B ring were such that an optimum hydrophobic condition exists and that an alkoxy substituent at the o-position as well as smaller substituents at the m-and p-positions are favorable for high activity. The analysis for the combined series of analogs where substituents on the A and B rings are varied showed the existence of an optimum hydrophobicity for the whole molecule for the transport process of the molecule, besides above-mentioned various position-specific structural effects.

  合成了α-[(苯氧乙基氨基)丙基]-α-苯基乙腈衍生物，这些衍生物在苯乙腈部分的苯环（A环）上、在四面体碳原子上，以及在苯氧部分的苯环（B环）上，具有不同的取代基，并表现出各种程度的α-阻断活性。采用物理化学取代基参数及回归技术，对活性的变化进行了定性和定量分析。A环上取代基的影响根据其疏水参数的抛物线函数进行合理化。至于四面体碳原子上的取代基，烷基基团被认为是高活性的理想选择。B环上取代基的影响表明，存在一个最佳的疏水条件，并且在邻位的烷氧取代基以及在间位和对位的较小取代基有利于高活性。针对A环和B环取代基变化的综合系列类似物的分析显示，在分子的运输过程中，整个分子的最佳疏水性存在，此外也考虑了上述不同位置特异的结构效应。
• Novel phenoxyalkylamine derivatives. II. Synthesis and Ca2+-antagonistic activities of .ALPHA.-alkyl-.ALPHA.-((phenoxypropylamino)propyl)-benzeneacetonitrile derivatives.
  作者：KAZUYA MITANI、TOSHIHIKO YOSHIDA、SHUNICHIRO SAKURAI、KOJI MORIKAWA、YUJI IWANAGA、EIICHI KOSHINAKA、HIDEO KATO、YASUO ITO

  DOI：10.1248/cpb.36.373

  日期：——

  α-Alkyl-α-[(phenoxypropylamino)propyl]benzeneacetonitrile derivatives containing various substituents on the ring of the benzeneacetonitrile moiety (A), the quaternary carbon atom and the ring of the phenoxy moiety (B) were prepared, and their Ca2+-antagonistic activities were evaluated. Among these compounds, the N-Me derivatives with a 3, 4, 5-(OMe)3 group on the A ring, an iso-Pr group on the quaternary carbon atom, and a m-OMe, 3, 5-(OMe)2, 3, 5-Me2 or 3, 4, 5-(OMe)3 group on the B ring were found to possess Ca2+-antagonistic activity higher than pA2=9. The effects of substitutions at the A ring, the quaternary carbon atom and the B ring are discussed.

  含有不同取代基的α-烷基-α-[(苯氧丙胺)丙基]苯乙腈衍生物被合成，并评估了它们的Ca2+拮抗活性。在这些化合物中，具有在A环上带有3, 4, 5-(OMe)3基团、在四级碳原子上带有iso-Pr基团，以及在B环上带有m-OMe、3, 5-(OMe)2、3, 5-Me2或3, 4, 5-(OMe)3基团的N-Me衍生物被发现具有高于pA2=9的Ca2+拮抗活性。讨论了在A环、四级碳原子和B环上的取代效应。
• Novel phenoxyalkylamine derivatives. IV. Synthesis, Ca2+-antagonistic activity and quantitative structure-activity analysis of .ALPHA.-isopropyl-.ALPHA.-(3-(3-(3-methoxyphenoxy)propylamino)propyl)-.ALPHA.-phenylacetonitrile derivatives.
  作者：KAZUYA MITANI、SHUNICHIRO SAKURAI、TOSHIHIRO SUZUKI、KOJI MORIKAWA、EIICHI KOSHINAKA、HIDEO KATO、YASUO ITO、TOSHIO FUJITA

  DOI：10.1248/cpb.36.4103

  日期：——

  α-Isopropyl-α-[3-[3-(3-methoxyphenoxy) propylamino] propyl] -α-phenylacetonitrile derivatives containing various substituents on the benzene ring (A ring) at the phenylacetonitrile moiety were prepared, and their Ca2+-antagonistic activity was evaluated. Among these compounds, the N-Me derivatives with m-OMe, p-F, p-Cl, 3, 4-(OMe) 2 and 3, 5-(OMe) 2 substituents on the A ring were found to show higher Ca2+-antagonistic activity than verapamil. The effect of substituents on the A ring was examined quantitatively using physicochemical substituent parameters and regression analysis. The analysis showed that substituents with a π value close to zero are favorable to the activity and that optimum steric conditions exist for m-and p-substituents, corresponding to those of m-OMe and p-F or p-Cl. The analysis for the whole series of analogs where substituents on the A ring, the benzene ring (B ring) at the phenoxy moiety and the quaternary carbon atom are simultaneously varied suggested that there is an optimum molecular hydrophobicity, perhaps participating in the transport process to the site of action, besides position-specific steric and hydrophobic effects.

  制备了α-异丙基-α-[3-[3-(3-甲氧基苯氧基)丙氨基]丙基]-α-苯乙腈衍生物，并评估了它们的 Ca2+ 拮抗活性。在这些化合物中，发现在 A 环上具有 m-OMe、p-F、p-Cl、3，4-(OMe) 2 和 3，5-(OMe) 2 取代基的 N-Me 衍生物比维拉帕米具有更高的 Ca2+ 拮抗活性。利用物理化学取代基参数和回归分析对 A 环上取代基的影响进行了定量研究。分析结果表明，π值接近于零的取代基对活性有利，而 m 和 p 取代基存在最佳立体条件，相当于 m-OMe 和 p-F 或 p-Cl。对同时改变 A 环、苯氧基苯环（B 环）和季碳原子上的取代基的全系列类似物进行的分析表明，除了特定位置的立体效应和疏水效应外，还存在最佳的分子疏水性，这可能参与了向作用部位的迁移过程。
• N,N-substituted cyclic amine derivatives
  申请人：Eisai Co., Ltd.

  公开号：US06737425B1

  公开（公告）日：2004-05-18

  The invention provides an N,N-substituted cyclic amine compound represented by the following formula (VIII): wherein A represents an aryl group etc.; E represents a group represented by the formula —CO— or a group represented by the formula —CHOH—; G represents an oxygen atom etc.; J represents an aryl group which may be substituted; R1 represents a lower alkyl group etc.; Alk represents a linear or branched lower alkylene group; n, v, w, x and y are independent of each other and each represents 0 or 1; and p represents 2 or 3, or a pharmacologically acceptable salt thereof. The compound of the present invention or a salt thereof is effective to treat a disease against which calcium antagonism is effective. The disease may include acute ischemic stroke, cerebral apoplexy, cerebral infarction, head trauma, cerebral nerve cell death, Alzheimer disease, Parkinson disease, amyotrophic lateral sclerosis, Huntington disease, cerebral circulatory metabolism disturbance, cerebral function disturbance, pain, spasm, schizophrenia, migraine, epilepsy, maniac-depressive psychosis, nerve degenerative diseases, cerebral ischemia, AIDS dementia complications, edema, anxiety disorder (generalized anxiety disorder) and diabetic neuropathy.

  本发明提供了一种由以下公式（VIII）表示的N，N-取代环状胺化合物：其中A代表芳基等；E代表由公式—CO—或公式—CHOH—表示的基团；G代表氧原子等；J代表可能被取代的芳基基团；R1代表较低的烷基等；Alk代表线性或支链较低的烷基烷基；n、v、w、x和y是独立的，每个代表0或1；p代表2或3，或其药学上可接受的盐。本发明的化合物或其盐对钙拮抗作用有效的疾病具有治疗作用。该疾病可能包括急性缺血性卒中、脑卒中、脑梗塞、头部创伤、脑神经细胞死亡、阿尔茨海默病、帕金森病、肌萎缩性侧索硬化、亨廷顿病、脑循环代谢障碍、脑功能障碍、疼痛、痉挛、精神分裂症、偏头痛、癫痫、躁郁症、神经退行性疾病、脑缺血、艾滋病痴呆并发症、水肿、焦虑症（广泛性焦虑症）和糖尿病神经病变。